2-Amino-5-Chlorothiazole-4-Carboxylic Acid Methyl Ester

How Disperse Red to Blue Chromophores Derive from a 5-Chloro-2-aminothiazole Backbone

Diazotisation of the primary amine on 2-amino-5-chlorothiazole-4-carboxylic acid methyl ester proceeds not via nitrous acid generated in situ from cheap sodium nitrite but rather with 40 wt% nitrosylsulfuric acid in concentrated H₂SO₄ at -2 °C to +2 °C. Because the thiazole ring is moderately electron‑deficient, the exotherm must be controlled by jacket cooling (–10 °C brine circulation) in a glass‑lined reactor equipped with Rushton turbine agitation: a temperature spike above +5 °C causes runaway decomposition of the diazonium salt with rapid gas evolution. A molar ratio of NaNO₂ to substrate of 1.00:1.02 is maintained, and the clear diazo liquor is clarified through a 0.5‑µm PTFE cartridge before coupling.

Coupling is run in a separate vessel containing the coupling component dispersed in ice/water with 2.0–3.0% sulfamic acid as nitrite scavenger. For a red‑orange chromophore, N,N‑diethylaniline (1.02 mol eq) is added as a fine emulsion at pH 3.8–4.2 maintained with sodium acetate buffer; for rubine to blue shades N‑ethyl‑N‑cyanoethylaniline or 3‑cyano‑6‑hydroxy‑4‑methyl‑2‑pyridone is employed. The coupling slurry is stirred for 4–6 h until a spot‑to‑spot TLC check (eluent: toluene/acetone 8:2 v/v) confirms complete consumption of the diazonium salt. The crude presscake is washed to conductivity <50 µS·cm⁻¹ and dried in a vacuum paddle dryer at 55 °C, –0.92 bar to a residual moisture below 0.5%.

The dried dye is standardised with sodium lignosulfonate dispersant to a strength of 200% (relative to standard depth) by batch‑type bead milling in a Netzsch MiniCer® mill charged with 0.3–0.4 mm yttria‑stabilised zirconia beads. Particle size is reduced to D₉₀ ≤1.0 µm measured by laser diffraction (ISO 13320:2020). The finished disperse dye paste or powder is applied to polyester by high‑temperature exhaust dyeing at 130 °C for 45–60 min (liquor ratio 1:10), giving build‑up to 4.0% o.w.f. without reduction clearing sensitivity. Compliance with ZDHC Manufacturing Restricted Substances List V3.1 and Oeko‑Tex® ECO PASSPORT requires that free arylamine content (EN 14362‑1:2017) is below 30 mg·kg⁻¹. The final commercial article is a granular low‑dusting shade for sportswear and automotive interior textiles where ISO 105‑B02 fastness ≥ 6 is specified by OEM standards.

The ester function is deliberately left intact during dye synthesis to adjust tinctorial strength; hydrolysis to the free carboxylic acid occurs only during the alkaline scour step carried out by dyehouses using 2 g·L⁻¹ NaOH at 80 °C, which can lead to a measurable bathochromic shift of 4–7 nm if not precisely time‑controlled.

SDHI Carboxamide Fungicides: The Sandmeyer Route from Protected Aminothiazole

Conversion of 2-amino-5-chlorothiazole-4-carboxylic acid methyl ester to 2,5‑dichlorothiazole-4‑carboxylic acid is the cornerstone for a family of succinate dehydrogenase inhibitor (SDHI) fungicides. The amine is diazotised in dilute HCl (6 M) with a stoichiometric deficiency of sodium nitrite (0.98 eq) at 0 °C to +3 °C, and the resulting diazonium solution is immediately transferred via a cooled transfer line into a stirred solution of CuCl in concentrated HCl maintained at –8 °C. The Sandmeyer chlorination evolves nitrogen vigorously; the headspace of the hastelloy C‑22 reactor is swept with a 20 mL·min⁻¹ nitrogen stream to keep the off‑gas oxygen content below 4 vol%. Crude 2,5‑dichlorothiazole-4‑carboxylic acid methyl ester is isolated by drowning on ice, centrifuged, and vacuum‑distilled (boiling range 118–122 °C at 10 mbar) to a purity of >98.5 area% by GC‑FID.

Alkaline hydrolysis with 1.5 eq LiOH in THF/water (3:1 v/v) at 40 °C yields the free carboxylic acid without decarboxylation; the acid chloride is then generated with SOCl₂ and catalytic DMF in toluene at 65 °C. Condensation with 2‑(1,3‑dimethylbutyl)‑3‑aminothiophene‑2‑carboxamide in ethyl acetate with triethylamine (1.2 eq) at 5 °C to ambient produces the core amide scaffold. The coupling mass is quenched with 5% citric acid, washed until neutral, and crystallised from methanol/water to give the technical active ingredient with a melting point of 168–171 °C.

The active is milled in an air jet mill to D₉₀ ≤4 µm and formulated as a 200 g·L⁻¹ suspension concentrate with ethylene oxide‑propylene oxide block copolymer and naphthalene sulfonate formaldehyde condensate dispersants. Final formulation specifications must comply with CIPAC Handbook J method MT 184 for suspensibility (>90% after 30 min) and MT 36.3 for wet sieve retention (<2% on 75 µm mesh). The commercial product is registered for control of Puccinia triticina (wheat leaf rust) and Cercospora arachidicola (early leaf spot of peanut) at an application rate of 150–200 g a.i.·ha⁻¹. Labelling includes the GHS09 pictogram; the LC₅₀ for Daphnia magna (OECD 202) is 0.12 mg·L⁻¹, mandating buffer zones near surface water.

When PI3Kδ Inhibitor Scaffolds Demand a 5‑Chlorothiazole Ester Handle

Pyrrolopyrimidine‑based phosphoinositide 3‑kinase δ (PI3Kδ) inhibitors utilise a 2‑amino‑5‑chlorothiazole‑4‑carboxamide motif as the solvent‑exposed hinge‑binding element that extends into the hydrophobic ribose pocket. The ester is hydrolysed to the carboxylic acid by K₂CO₃ in aqueous methanol (4 eq, reflux 2 h) and directly used in a HATU‑mediated coupling with the primary amine of the advanced kinase inhibitor intermediate in the presence of N,N‑diisopropylethylamine (1.5 eq) in anhydrous N,N‑dimethylformamide at 20 °C. The amidation is complete within 45 min; residual HATU‑related by‑products are extracted by aqueous 5% LiCl washes. A precise molar equivalent of 1.00:1.03 (acid:amine) is enforced to minimise the formation of the bis‑acylated dimer which co‑elutes with the product in normal‑phase chromatography (hexane/ethyl acetate 7:3). The crude product is purified by flash chromatography on spherical silica (pore Ø 60 Å, particle 30–50 µm) with a loading of 1:30 w/w, giving an isolated yield of 81% and a purity of >98.7%.

The final API is isolated as a methanesulfonate salt by treatment with 1.0 eq methanesulfonic acid in isopropyl acetate/ethanol, crystallising in a plate‑like morphology with a D₉₀ of 45–60 µm after wet milling in a cone mill fitted with a 0.457‑mm round‑hole screen. The tablet core formulation comprises the API (100 mg free‑base equivalent), microcrystalline cellulose (72 mg), croscarmellose sodium (5 mg), and magnesium stearate (1 mg), direct‑compressed on a rotary press at 55 kN to a hardness of 80–110 N. Dissolution testing per USP <711> Apparatus 2 @ 50 rpm in 900 mL 0.01 M HCl shows >85% release in 30 min. ICH Q3D elemental impurity limits require Pd residue (from the Suzuki coupling in the scaffold assembly) to be below 10 µg·g⁻¹ and Cu below 250 µg·g⁻¹, measured by ICP‑MS after closed‑vessel microwave digestion. Distribution of the finished dosage form for chronic lymphocytic leukaemia indication is contingent on a stability programme at 25 °C/60% RH for 36 months per ICH Q1A(R2).

In glass‑lined kilo‑lab trials, the rate of addition of HATU must be slowed to control an adiabatic temperature rise of 5–7 °C above set point; otherwise, formation of the nitrilium side product derived from O‑acylisourea rearrangement can increase to 3–5% (LCAP) from a baseline of 0.6%. Processing at 15 °C with dropwise addition of the acid‑HATU pre‑activation mixture over 20 minutes keeps the unwanted impurity below 1.0%.

The 2‑amino‑5‑chlorothiazole‑4‑carboxylic acid methyl ester is also used as a precursor to a bidentate ancillary ligand in green‑emitting heteroleptic iridium(III) complexes for phosphorescent organic light‑emitting diodes (PhOLEDs). Hydrolysis with 1.2 eq NaOH in ethanol/water at reflux gives the sodium carboxylate, which is protonated and then deprotonated with tetra‑n‑butylammonium hydroxide to furnish the tetrabutylammonium salt – a key intermediate that reacts with the chloro‑bridged dimer [(C^N)₂Ir(μ‑Cl)]₂ in 2‑ethoxyethanol under nitrogen at 130 °C for 12 h. The 5‑chloro substituent lowers the HOMO level of the resulting complex by approximately 0.15 eV compared to the unsubstituted thiazole analogue, as determined by cyclic voltammetry against ferrocenium/ferrocene internal standard. Column chromatography on neutral alumina (Brockmann activity I) with dichloromethane/methanol (99:1 v/v) isolates the facial isomer in 62% yield.

The deep green emitter is co‑sublimed with a hole‑transport host at 10⁻⁶ mbar in a vacuum thermal evaporation chamber with a deposition rate of 0.2 nm·s⁻¹. A top‑emission OLED stack with a cavity length tuned to the first‑order microcavity resonance delivers an electroluminescence λ_max of 522 nm, CIE coordinates (0.28, 0.66), and an external quantum efficiency of 18.5% at a luminance of 1000 cd·m⁻² (measurement per JIS C 8105‑2). Device lifetime LT₉₅ at 4000 cd·m⁻² exceeds 6000 h. The emitter powder is packed under argon atmosphere in double‑seamed stainless‑steel bottles with a moisture specification of <10 ppm H₂O and <5 ppm O₂ (headspace GC‑TCD). The material is exempt from registration under Annex IV of Regulation (EC) No 1907/2006 as a site‑limited intermediate used in photonic device fabrication, while the finished appliance complies with the exemption for cadmium in display components of RoHS 2011/65/EU Annex III. Transport follows ADR special provision 327 for manufactured articles containing dangerous substances; the product is classified UN 3082 (environmentally hazardous substance, solid, n.o.s., PG III) when shipped as a laboratory‑scale sample.